Search Results 111-120 of 16843 for Humira

  1. Drugs and Supplements that Start with G - Mayo Clinic

    Explore a comprehensive list of prescription and over-the-counter medications starting with the letter “G” to learn about drug side effects, proper use and ...

  2. Consumer health basics

    Take charge of your health. Know your options. Use medicines and supplements wisely. Be informed and ask questions of your health care professionals.

  3. A Study of Response, Survival, Safety, and Tolerability of Lenvatinib for the Treatment of Anaplastic Thyroid Cancer - Mayo Clinic

    The purpose of this study is to evaluate response, survival, safety, and tolerability of treatment with lenvatinib for patients who have anaplastic thyroid ...

  4. https://www.mayoclinic.org/arabic_patient_consumer_faq.xml

  5. shingles Archives - Mayo Clinic News Network

    ... (Humira), infliximab (Remicade), etanercept (Enbrel), radiation or chemotherapy; Have cancer that affects the bone marrow or lymphatic system, such as ...

  6. A Study to Test the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer - Mayo Clinic

    Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as ...

  7. Expanded Access Protocol of Patisiran for Patients With Hereditary ATTR Amyloidosis (hATTR) - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  8. Evaluation of Immunophenotype Signatures in Hypereosinophilia-Associated Disorders - Mayo Clinic

    About this study. The purpose of this study is to characterize the immunophenotype of individuals with hypereosinophilia-associated cardiovascular, ...

  9. A Study Of The Drugs Selumetinib Vs. Carboplatin And Vincristine In Patients With Low-Grade Glioma - Mayo Clinic

    About this study. This study aims to demonstrate that the efficacy of treatment with selumetinib as measured by event-free survival (EFS) is non-inferior ...

  10. MM-398 (Nanoliposomal Irinotecan, Nal-IRI) to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure Tumor Associated Macrophages and to Predict Patient Response to Treatment - Mayo Clinic

    MM-398 (Nanoliposomal Irinotecan, Nal-IRI) to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure ...